HCM FPX 5314 Assessment 3 Value-Based Purchasing and Shared Risk Models
Student Name
Capella University
HCM-FPX314 Driving Health Care Results
Professor Name
Submission Date
Value-based purchasing and Shared Risk Models are fast becoming key tools toward healthcare delivery transformation in general healthcare delivery, let alone in the Appalachian regional healthcare system. With such a background of access and outcome of health care being problematic in the Appalachian region, the introduction of value-based sharing and Shared Risk Models is most likely to bring drastic change to patient care, as presupposed Leao et al. (2023). These models can remove inequities and give a focus on the health of the people by using health outcomes as a foundation for financial rewards. The implications, advantages, and disadvantages of the implementation of these models in the Appalachian healthcare environment will be discussed. Value-based purchasing models are very important in reshaping healthcare delivery. This is the model of linking reimbursement of providers to the effectiveness and efficiency of care. Below are its parts: The effects of VBP on health management’s budgetary responsibilities relate to the “knotted” payments that are for quality and efficiency, not volume. The program of the CMS Hospital Value-Based Purchasing Program means that hospitals with poor performance on quality measures lose payments for these poor scores, making them financially unsustainable (Norton et al., 2021). While some positive findings were found in some hospitals on hospital-acquired conditions, the overall impact of VBP is unclear and indicative of problems in implementation. Besides, healthcare companies must put money into know-how and data analytics to monitor performance, which is not an inexpensive task at the start, however effective over time, given the effect it has on patients and on readmission rates. Last but not least, VBP demands a periodic audit of the financial management processes, emphasizing quality and efficiency, taking into consideration the new reimbursement paradigms. Shared risk models are meant to achieve the appropriate alignment of financial risk providers and payers, regarding population health management, in a manner that will lower costs and ensure a higher quality. Within these models, providers are frequently left to absorb the risk of revenue collected and the cost of care provided to patients delivered by Accountable Care Organizations (ACOs). For instance, the Medicare Shared Savings Program realized its effectiveness, with a saving of $1.8 billion in 2022, as a great majority of ACOs across the board earned shared savings payments (U.S. Centers for Medicare & Medicaid Services, 2021). This is because the providers can coordinate the delivery of care and manage patients optimally. The downside of shared risk models is that they do need the right data to be analysed to track performance, and the cost risks to the providers if they do not meet the agreed cost thresholds. In a nutshell, a shared risk model succeeds based on the capability of the providers to know the care costs and to use data in quality enhancement and management of the financial risks. In the healthcare industry, the healthcare units can be significantly affected by shared risk models, including Accountable Care Organizations (ACOs) and Value-Based Care (VBC) models. These models are designed to move the financial risk away from payers to providers, thereby encouraging the provision of cost-effective care and improved patient outcomes. An ACO could, for instance, be given a set budget to oversee a population’s health, and then the provider would share in the savings if it’s able to stay within the budget. That can result in greater investment in the prevention and care coordination services, which may lower total costs (U.S. Centers for Medicare & Medicaid Services, 2021). These models also carry risk, though: if care may not be managed effectively within the budget, or if the outcomes of the care do not live up to expectations, the provider may suffer financially. These financial considerations must be managed and planned carefully to ensure that shared risk models also lead to cost savings and quality care. Evidence-based strategies will be important in the culture of the healthcare organization in organizing the implementation of the best practices in the clinical decision-making process. This is supported by studies indicating that over 50% of QI interventions are not successful, not due to people not knowing what to do, but because they don’t do it right. For instance, research indicates that leadership plays a pivotal role in translating and implementing quality programs, such as how the top management can either facilitate or obstruct the role of middle management in the initiatives by providing resources and concentrating on Restivo et al. (2022). Second, well-developed working relationships between managerial and clinical leaders help to build commitment to implementing quality efforts. Other health care systems, such as Medicare Shared Savings, have shown cost savings and quality improvements by establishing performance targets and tracking a health care system’s metrics. Healthcare organizations can foster a culture of improvement that will ensure improved patient care and overall organizational effectiveness by utilizing and implementing these evidence-based strategies. The assessment was geared toward changes within the healthcare system that have been precipitated by Value-Based Purchasing and shared risk models. Care models such as these encourage quality and productivity of care, and tie payment to the value of services. Performance management, financial responsibility, decision making, and culture of performance improvement are all key elements of VBP models. In addition, we see some effect on the budget from the shared risk models. On top of that, we underline that technology and analytics shall not be a mere cost but rather a sound investment. Finally, best practices in the way effective change is managed should become ingrained in the culture of the organization, ensuring that a legacy is created for the future of healthcare and patients’ lives. All of these methods will play a crucial role in healthcare and maintaining a healthy life in the future.Value-Based Purchasing and Shared Risk Models
Components of a Value-Based Purchasing Model
Standardized Performance Measurement:
Incentives for Quality Improvement:
Patient-Cantered Care Coordination:
Data-Driven Decision Making:
Flexibility and Adaptability:
Budgetary and Financial Implications of Value-Based Purchasing
Examples of Shared Risk Models
Budgetary and Financial Implications
Evidence-based Strategies to Develop an Effective Organizational Culture
Conclusion
Step-by-Step Instructions to write
HCM FPX 5314 Assessment 3
Contact us today and receive expert step-by-step instructions for HCM FPX 5314 Assessment 3.
Instructions File For
HCM FPX 5314 Assessment 3
Contact us to get the instruction file.
Scoring Guide For
HCM FPX 5314 Assessment 3
Contact us to get the scoring guide.
References in APA Format For
HCM FPX 5314 Assessment 3
Below are the references used in HCM FPX 5314 Assessment 3 Value-Based Purchasing and Shared Risk Models:
Backhouse, A., & Ogunlayi, F. (2020). Quality improvement into practice. BMJ, 368(1). https://www.bmj.com/content/368/bmj.m865
Leao, D. L. L., Cremers, H.-P., van Veghel, D., Pavlova, M., & Groot, W. (2023). The impact of value-based payment models for networks of care and transmural care: A systematic literature review. Applied Health Economics and Health Policy, 21(3). https://doi.org/10.1007/s40258-023-00790-z
Leao, D. L. L., Pavlova, M., & Groot, W. N. J. (2024). How to facilitate the introduction of value-based payment models? The International Journal of Health Planning and Management, 39(2), 583-592. https://doi.org/10.1002/hpm.3746
Norton, E. C., Li, J., Das, A., Ryan, A. M., & Chen, L. M. (2021). Medicare’s hospital value-based purchasing program values quality over quality. Medical Decision Making, 42(1), 0272989X2110171. https://doi.org/10.1177/0272989×211017105
Restivo, V., Minutolo, G., Battaglini, A., Carli, A., Capraro, M., Gaeta, M., Odone, A., Trucchi, C., Favaretti, C., Vitale, F., & Casuccio, A. (2022). Leadership effectiveness in healthcare settings: A systematic review and meta-analysis of cross-sectional and before-after studies. International Journal of Environmental Research and Public Health, 19(17), 1-13. NCBI. https://doi.org/10.3390/ijerph191710995
U.S. Centers for Medicare & Medicaid Services. (2021). Accountable Care Organizations (ACOs): General information | CMS. Www.cms.gov. https://www.cms.gov/priorities/innovation/innovation-models/aco
Best Capella professors to choose from for
HCM-FPX314 Class
- Bradly E. Roh
- Jama Bradley
(FAQs) related to
HCM FPX 5314 Assessment 3
Question 1: What is HCM FPX 5314 Assessment 3 about?
Answer 1: Analyzing value-based purchasing, shared risk models’ financial impact and organizational strategies.
Question 2: Where can I get expert help with HCM FPX 5314 Assessment 3?
Answer 2: Get expert guidance for HCM FPX 5314 Assessment 3 by visiting TutorsAcademy.co.
Do you need a tutor to help with this paper for you within 24 hours
- 0% Plagiarised
- 0% AI
- Distinguish grades guarantee
- 24 hour delivery
Previous Assessment:

